Page last updated: 2024-11-02

pentamidine and Tuberculosis, Multidrug-Resistant

pentamidine has been researched along with Tuberculosis, Multidrug-Resistant in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Tuberculosis, Multidrug-Resistant: Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanvatirth, P1
Jeeves, RE1
Bacon, J1
Besra, GS1
Alderwick, LJ1

Other Studies

1 other study available for pentamidine and Tuberculosis, Multidrug-Resistant

ArticleYear
Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    PloS one, 2019, Volume: 14, Issue:3

    Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Drug Design; Drug Reposit

2019